Successful "American Dynamism" companies de-risk hardware development by initially using off-the-shelf commodity components. Their unique value comes from pairing this accessible hardware with sophisticated, proprietary software for AI, computer vision, and autonomy. This approach lowers capital intensity and accelerates time-to-market compared to traditional hardware manufacturing.

While public surgical videos from YouTube can bootstrap initial models, Andromeda's defensible data moat is built from capturing proprietary data during live procedures. This includes robot kinematics and force feedback, which is impossible to source elsewhere and essential for training autonomy.

The biotech industry often believes its processes require unique, specialized robots. In reality, well-proven robotics from industrial and logistics sectors are applicable. The key is thoughtful system design and adaptation (e.g., sterilization, end effectors), not reinventing core technology.

By releasing new software features weekly based on direct feedback from surgeons in the clinic, Andromeda has compressed the typical multi-year MedTech development cycle into weeks. This rapid, customer-centric improvement loop is shocking to the traditionally slow-moving medical industry.

RoboCath deliberately designed its platform to be compatible with all device brands. This open-ecosystem approach lowers the barrier to adoption, as physicians don't need to abandon their preferred tools, a key advantage over competitors who might pursue exclusive partnerships.

Frontline Medical chose to develop the Cobra OS not because it was their most revolutionary concept, but because it was manufacturable with limited resources. They prioritized the idea that 'checked all the boxes' for feasibility, market success, and patient impact, ensuring they could bring a product to market.

The venture capital mantra that "hardware is hard" is outdated for the American Dynamism category. Startups in this space mitigate risk by integrating off-the-shelf commodity hardware with sophisticated software. This avoids the high capital costs and unpredictable sales cycles of consumer electronics.

Carvolix is strategically designing its robotic and AI platform to be compatible with heart valves from all major manufacturers like Edwards and Medtronic. This "agnostic" approach allows them to sell *to* the entire ecosystem rather than competing *within* it, positioning their technology as a universal upgrade that any hospital can adopt regardless of its preferred valve supplier.

Building custom components for early-stage prototypes is slow and expensive. A faster, more cost-effective approach is to buy existing commercial products that contain similar components, then scavenge those parts for your prototype. This enables rapid concept validation without investing in custom design and manufacturing.